Skip to main content
Clinical Trials/NCT02502201
NCT02502201TerminatedNot Applicable

Effect of the Environment on Six-minute Walk Test Performance in Individuals With Alpha-1 Antitrypsin Deficiency-Related Chronic Obstructive Pulmonary Disease

University of Florida1 site in 1 country27 target enrollmentStarted: October 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
27
Locations
1
Primary Endpoint
Change in the meters walked during the six-minute walk test between the two groups.

Study Overview

Brief Summary

The purpose of this research study is to determine the effect of the environment on six-minute walk test performance in individuals with chronic obstructive pulmonary disease due to alpha-1 antitrypsin deficiency. The aim of the study is to determine the environmental impact on physical performance in this population to determine if any factors influence quality of life. This study was developed to evaluate the efficacy of the using the indoor six-minute walk test to determine eligibility for ambulatory oxygen therapy.

Detailed Description

Participants will be asked to come to the Clinical Research Center (CRC) for a visit lasting about one hour. Participants will be asked to review and sign an informed consent document to participate in this trial. If participants agree to participate and sign the consent, the following procedures will be done. If they have not had pulmonary function testing performed in the past 18 months, standard spirometry testing will be performed. Participants will perform two six-minute walk tests, one indoors and one outdoors. First, they will be randomly assigned to perform either the indoor or outdoor testing first. Then participants will have their vital signs taken, perform the first six-minute walk study and immediately after have their vital signs taken again. Participants will have a rest period between the two six-minute walk tests of at least 30 minutes. Participants will then perform the second six-minute walk test with the same above procedures for the first test.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age above 18 years.
  • •Have a diagnosis of congenital Alpha-1 Antitrypsin Deficiency with an allelic combination of ZZ.
  • •Have a Forced Expiratory Volume in 1 second (FEV1)< 50% of predicted and FEV1/forced vital capacity (FVC) < 70% (Global Initiative for Chronic Obstructive Lung Disease [GOLD] stage II, III, or IV).
  • •Not currently prescribed Oxygen replacement at a rate of greater than 2 liters.
  • •Willing and able to perform two six-minute walk tests.
  • •Willing and able to provide written informed consent.

Exclusion Criteria

  • •Subject has had a moderate or severe pulmonary exacerbation during the 4 weeks before the study visit.
  • •History of lung transplant.
  • •Severe concomitant disease (e.g., congestive heart failure, clinically significant pulmonary fibrosis, malignant disease [with the exception of skin cancers other than melanoma], history of acute hypersensitivity pneumonitis reaction, or current chronic hypersensitivity pneumonitis).
  • •Unwilling or unable to perform six-minute walk testing.
  • •Mentally challenged adult subjects who cannot give independent informed consent.
  • •In the opinion of the investigator the subject may have compliance problems with the protocol and the procedures of the protocol.
  • •American Thoracic Society listed absolute contraindications to six-minute walk test: unstable angina or myocardial infarction during previous month.

Arms & Interventions

six-minute walk study indoors first

Active Comparator

Participants randomized to indoor six-minute walk test first

Intervention: six-minute walk study indoors (Other)

six-minute walk study outdoors first

Experimental

Participants randomized to outdoor six-minute walk test first

Intervention: six-minute walk study outdoors (Other)

six-minute walk study indoors second

Active Comparator

Participants randomized to indoor six-minute walk test second

Intervention: six-minute walk study indoors (Other)

six-minute walk study outdoors second

Experimental

Participants randomized to outdoor six-minute walk test second

Intervention: six-minute walk study outdoors (Other)

Outcomes

Primary Outcomes

Change in the meters walked during the six-minute walk test between the two groups.

Time Frame: baseline

Secondary Outcomes

  • Change in Borg Scale for shortness of breath between the two groups(baseline)
  • Change in Borg Scale for fatigue between the two groups(baseline)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials